ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly other — net, (income) expense ($M) ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2025
-571
Period ended Dec 31, 2025
Change on a year earlier
+160.7%
-219 in FY2024
History
19 years
Since FY2007
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other — net, (income) expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -571 | +160.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | -219 | -325.8% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 97 | -130.2% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | -321 | +59.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | -202 | -117.2% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 1,172 | +301.9% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 292 | +100.3% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 146 | -51.7% | Form 10-K (filed 2020-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 302 | +167.3% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 113 | +12.1% | Form 10-K (filed 2019-02-19) ↗ |
| FY2015 | Dec 31, 2015 | 101 | -70.5% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 341 | -34.4% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 519 | -23.0% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 674 | -476.5% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | -179 | +3,480.0% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | -5 | -97.8% | Form 10-K (filed 2012-02-24) ↗ |
| FY2009 | Dec 31, 2009 | -230 | -979.3% | Form 10-K (filed 2012-02-24) ↗ |
| FY2008 | Dec 31, 2008 | 26.1 | -78.6% | Form 10-K (filed 2011-02-22) ↗ |
| FY2007 | Dec 31, 2007 | 122 | – | Form 10-K (filed 2010-02-22) ↗ |
Cite this data
StockData. (2026). Eli Lilly Other — net, (income) expense ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_nonop
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.